KIMBERLY COOK: Open Payments
NPI 1164851598 · PIKEVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$810 in 42 payments from 14 companies in 2025. Trend: 2023 $643 · 2024 $1,107 · 2025 $810
Food & beverage: $810
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 11 | $146 |
| Merck Sharp & Dohme LLC | 6 | $111 |
| Dexcom, Inc. | 3 | $99 |
| Mallinckrodt Hospital Products Inc. | 3 | $84 |
| UCB, Inc. | 4 | $64 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $59 |
| PFIZER INC. | 3 | $44 |
| Merz Pharmaceuticals, LLC | 2 | $41 |
| Baxter Healthcare | 2 | $41 |
| Galderma Laboratories, L.P. | 1 | $39 |
Products named: ZERBAXA, TAVNEOS, Dexcom G6 Transmitter, ACTHAR, Bimzelx, OFEV, XELJANZ, Xeomin.
Industry payments across KY — which companies pay providers there.
